Cargando…
Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METH...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344283/ https://www.ncbi.nlm.nih.gov/pubmed/34353879 http://dx.doi.org/10.1136/bmjdrc-2020-002047 |
_version_ | 1783734458924400640 |
---|---|
author | Inoue, Kosuke Semba, Eriko Yamakawa, Tadashi Terauchi, Yasuo |
author_facet | Inoue, Kosuke Semba, Eriko Yamakawa, Tadashi Terauchi, Yasuo |
author_sort | Inoue, Kosuke |
collection | PubMed |
description | INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METHODS: Our study included 8795 adults from the National Health and Nutrition Examination Survey 2005–2014. Mortality data were ascertained through 2015. Multivariable Cox proportional-hazards models were used to estimate adjusted HRs (aHRs) for all-cause mortality according to 2-hour plasma glucose levels during the 75 g oral glucose tolerance test—normal glucose tolerance (NGT), <140 mg/dL; impaired glucose tolerance (IGT), 140–199 mg/dL; and diabetes, ≥200 mg/dL. We then examined the associations of glucose tolerance status and self-reported physician-diagnosed sleep disorders (yes vs no) or sleep duration (<7 vs ≥7 hours) with all-cause mortality. RESULTS: During follow-up (median, 5.6 years), the diabetes group had a higher risk of all-cause mortality compared with the NGT group (aHR (95% CI)=1.93 (1.41 to 2.64)), but not the IGT group (aHR (95% CI)=1.19 (0.90 to 1.59)). When we categorized participants according to glucose tolerance status and sleep disorders, the IGT group with sleep disorders had a higher risk of all-cause mortality (aHR (95% CI)=2.03 (1.24 to 3.34)) compared with the NGT group without sleep disorders. Both diabetes groups with and without sleep disorders also showed high mortality risks. The results were consistent when we used sleep duration instead of sleep disorders. CONCLUSIONS: Using the most updated US national data, we found a high risk of all-cause mortality among individuals with IGT having sleep disorders or short sleep duration as well as those with diabetes. Future investigations are needed to identify whether and what kind of sleep management is beneficial for people with impaired glucose metabolism to prevent early death. |
format | Online Article Text |
id | pubmed-8344283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83442832021-08-20 Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population Inoue, Kosuke Semba, Eriko Yamakawa, Tadashi Terauchi, Yasuo BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: Sleep disorders and short sleep duration are common symptoms among people with diabetes. However, the evidence is limited about the associations of post-challenge hyperglycemia and sleep quality or quantity with all-cause mortality in the US general population. RESEARCH DESIGN AND METHODS: Our study included 8795 adults from the National Health and Nutrition Examination Survey 2005–2014. Mortality data were ascertained through 2015. Multivariable Cox proportional-hazards models were used to estimate adjusted HRs (aHRs) for all-cause mortality according to 2-hour plasma glucose levels during the 75 g oral glucose tolerance test—normal glucose tolerance (NGT), <140 mg/dL; impaired glucose tolerance (IGT), 140–199 mg/dL; and diabetes, ≥200 mg/dL. We then examined the associations of glucose tolerance status and self-reported physician-diagnosed sleep disorders (yes vs no) or sleep duration (<7 vs ≥7 hours) with all-cause mortality. RESULTS: During follow-up (median, 5.6 years), the diabetes group had a higher risk of all-cause mortality compared with the NGT group (aHR (95% CI)=1.93 (1.41 to 2.64)), but not the IGT group (aHR (95% CI)=1.19 (0.90 to 1.59)). When we categorized participants according to glucose tolerance status and sleep disorders, the IGT group with sleep disorders had a higher risk of all-cause mortality (aHR (95% CI)=2.03 (1.24 to 3.34)) compared with the NGT group without sleep disorders. Both diabetes groups with and without sleep disorders also showed high mortality risks. The results were consistent when we used sleep duration instead of sleep disorders. CONCLUSIONS: Using the most updated US national data, we found a high risk of all-cause mortality among individuals with IGT having sleep disorders or short sleep duration as well as those with diabetes. Future investigations are needed to identify whether and what kind of sleep management is beneficial for people with impaired glucose metabolism to prevent early death. BMJ Publishing Group 2021-08-05 /pmc/articles/PMC8344283/ /pubmed/34353879 http://dx.doi.org/10.1136/bmjdrc-2020-002047 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology/Health services research Inoue, Kosuke Semba, Eriko Yamakawa, Tadashi Terauchi, Yasuo Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title | Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title_full | Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title_fullStr | Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title_full_unstemmed | Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title_short | Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population |
title_sort | associations of impaired glucose tolerance and sleep disorders with mortality among the us general population |
topic | Epidemiology/Health services research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344283/ https://www.ncbi.nlm.nih.gov/pubmed/34353879 http://dx.doi.org/10.1136/bmjdrc-2020-002047 |
work_keys_str_mv | AT inouekosuke associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation AT sembaeriko associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation AT yamakawatadashi associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation AT terauchiyasuo associationsofimpairedglucosetoleranceandsleepdisorderswithmortalityamongtheusgeneralpopulation |